SEC Form 4 · accession 0001209191-16-136955
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kalidip Choudhury
Officer — VP of Business Development
Period of report
Aug 12, 2016
Accepted (ET)
Aug 15, 2016 · 2:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options | $7.71 | Dec 14, 2015 | M | 50,000 | A | Dec 14, 2016 | Dec 13, 2025 | Common Stock | 50,000 | 50,000 | D |
Remarks
Kalidip Choudhury was hired on December 14, 2015. on August 14, 2016, the Board approved to add him as section 16 officer.